linda yaccarino - Search News

News

Linda Yaccarino joins health tech platform eMed

Linda Yaccarino, After Exiting Elon Musk’s X, Tapped as CEO of Weight-Loss Drug Management Company eMed

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform for GLP-1/GIP population health management.” That refers to the class of weight-loss drugs like Wegovy and Ozempic.

Insider on MSN · 9h

Linda Yaccarino is ditching Musk world for weight-loss drugs. It makes total sense.

Linda Yaccarino is ditching Musk world for weight-loss drugs. It makes total sense. Linda Yaccarino was named CEO of EMed, a telehealth company, a month after leaving X. Yaccarino's tenure at X was turbulent and involved doing a lot of damage control for Elon Musk.

TechCrunch on MSN · 11h

Linda Yaccarino joins health tech platform eMed as CEO after leaving X

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her "undeniable ability to negotiate new partnerships."

12h

Linda Yaccarino appointed chief executive of telehealth start-up

Linda Yaccarino has been appointed as chief executive of a telehealth start-up that offers weight loss medication, weeks ...

11hon MSN

Former X CEO Yaccarino takes helm at GLP-1 focused telehealth firm eMed

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results